A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

Clinical trials offer a unique treatment experience when you live with myeloproliferative disorders. Lower cost of care, direct access to a specialized MDS medical team, and the opportunity to try new ...

One expert explains why most of the time clinical trial enrollment is ‘the correct answer’ for patients. By participating in clinical trials, patients with cancer have the opportunity to find ...

Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...

Treatment through a clinical trial may be an option for some people with leukemia. Several factors may influence your decision to join a clinical trial, so it’s important to gather as much information ...

NEW YORK, Nov. 5, 2024 /PRNewswire/ -- Research Grid, the AI startup that helps medical research institutions automate back-office admin for clinical trials, has raised a $6.5m seed round. The company ...